Global Imipenem (CAS 64221-86-9) Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 100 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Imipenem (Primaxin) is an intravenous ?-lactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in 1980. It was the first member of the carbapenem class of antibiotics. Carbapenems are highly resistant to the ?-lactamase enzymes produced by many multiple drug-resistant Gram-negative bacteria, thus play a key role in the treatment of infections not readily treated with other antibiotics.

This report provides detailed analysis of worldwide markets for Imipenem (CAS 64221-86-9) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Imipenem (CAS 64221-86-9) market and further lays out an analysis of the factors influencing the supply/demand for Imipenem (CAS 64221-86-9), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Imipenem (CAS 64221-86-9) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Imipenem (CAS 64221-86-9) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Imipenem (CAS 64221-86-9) market are Hospira (USA), Unimark Remedies (India), ACS Dobfar (Italy), High Tech Pharm (Korea), Zhejiang Hisun (China), TUL (China), Shenzhen Haibin (China), Zhejiang Jiuzhou (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Imipenem (CAS 64221-86-9) industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Imipenem (CAS 64221-86-9) Production Volume (Unit) 2011-2016
Figure Global Imipenem (CAS 64221-86-9) Production Value (M USD) 2011-2016
Figure Top 10 Imipenem (CAS 64221-86-9) Vendors Production Volume Share 2015
Figure Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value Share 2015
Figure Regional Imipenem (CAS 64221-86-9) Production (Unit) 2015
Figure Regional Imipenem (CAS 64221-86-9) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Imipenem (CAS 64221-86-9) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Imipenem (CAS 64221-86-9) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Imipenem (CAS 64221-86-9) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Imipenem (CAS 64221-86-9) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Imipenem (CAS 64221-86-9) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Imipenem (CAS 64221-86-9) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Imipenem (CAS 64221-86-9) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Imipenem (CAS 64221-86-9) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Imipenem (CAS 64221-86-9) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Imipenem (CAS 64221-86-9) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Imipenem (CAS 64221-86-9) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2011-2016
Table Global Key Imipenem (CAS 64221-86-9) Vendors Production Share 2011-2016
Figure Global Imipenem (CAS 64221-86-9) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2011-2016
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2011
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2012
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2013
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2014
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2015
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production (Unit) 2016
Figure Imipenem (CAS 64221-86-9) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Imipenem (CAS 64221-86-9) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Imipenem (CAS 64221-86-9) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Imipenem (CAS 64221-86-9) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Imipenem (CAS 64221-86-9) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Imipenem (CAS 64221-86-9) Production Value (M USD), Growth Rate
Table Global Key Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2011-2016
Table Global Key Imipenem (CAS 64221-86-9) Vendors Production Value Share 2011-2016
Figure Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2011
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2012
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2013
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2014
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2015
Table Global Top 10 Imipenem (CAS 64221-86-9) Vendors Production Value (M USD) 2016
Figure Imipenem (CAS 64221-86-9) Prices (USD/Ton) 2016
Figure Imipenem (CAS 64221-86-9) Gross Margin 2016
Figure Imipenem (CAS 64221-86-9) Production Value (M USD) By Region 2011-2016
Table Global Imipenem (CAS 64221-86-9) Production Value (M USD) 2011-2016
Table Global Imipenem (CAS 64221-86-9) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Imipenem (CAS 64221-86-9) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Imipenem (CAS 64221-86-9) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Imipenem (CAS 64221-86-9) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Imipenem (CAS 64221-86-9) Production Value Share Trend
Figure Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2015
Table Regional Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2011-2016
Table Regional Imipenem (CAS 64221-86-9) Consumption Volume Share 2011-2016
Figure Imipenem (CAS 64221-86-9) Consumption in North America 2011-2016
Figure Imipenem (CAS 64221-86-9) Consumption in EMEA 2011-2016
Figure Imipenem (CAS 64221-86-9) Consumption in Asia-Pacific 2011-2016
Figure Imipenem (CAS 64221-86-9) Consumption in ROW 2011-2016
Figure Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2016
Table Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2011-2016
Table Global Imipenem (CAS 64221-86-9) Consumption Volume Share 2011-2016
Figure Global Imipenem (CAS 64221-86-9) Production (Unit) Forecast 2016-2021
Table Global Imipenem (CAS 64221-86-9) Production (Unit) 2016-2021
Table Global Imipenem (CAS 64221-86-9) Production Share 2016-2021
Figure North Imipenem (CAS 64221-86-9) Production (Unit) Forecast 2016-2021
Figure EMEA Imipenem (CAS 64221-86-9) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Imipenem (CAS 64221-86-9) Production (Unit) Forecast 2016-2021
Figure ROW Imipenem (CAS 64221-86-9) Production (Unit) Forecast 2016-2021
Figure Global Imipenem (CAS 64221-86-9) Revenue (M USD) Forecast 2016-2021
Table Global Imipenem (CAS 64221-86-9) Revenue (M USD) 2016-2021
Table Global Imipenem (CAS 64221-86-9) Revenue Share 2016-2021
Figure North America Imipenem (CAS 64221-86-9) Revenue (M USD) Forecast 2016-2021
Figure EMEA Imipenem (CAS 64221-86-9) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Imipenem (CAS 64221-86-9) Revenue (M USD) Forecast 2016-2021
Figure ROW Imipenem (CAS 64221-86-9) Revenue (M USD) Forecast 2016-2021
Figure Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2016-2021
Table Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2016-2021
Table Global Imipenem (CAS 64221-86-9) Consumption Volume Share 2016-2021
Figure North America Imipenem (CAS 64221-86-9) Consumption (Unit) Forecast
Figure EMEA Imipenem (CAS 64221-86-9) Consumption (Unit) Forecast
Figure Asia-Pacific Imipenem (CAS 64221-86-9) Consumption (Unit) Forecast
Figure ROW Imipenem (CAS 64221-86-9) Consumption (Unit) Forecast
Figure Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2021
Table Global Imipenem (CAS 64221-86-9) Consumption Volume (Unit) 2016-2021
Table Global Imipenem (CAS 64221-86-9) Consumption Volume Share 2016-2021
Table Key Strategies for Imipenem (CAS 64221-86-9) Multinational Corporations
Table Key Strategies for Imipenem (CAS 64221-86-9) Emerging-Market Players